Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Lundberg

Showing results (131-140 of 172) with videos related to

Pageof 18
Sort By:
Leukemia Research|September 15, 2009
Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemiaSteven L Allen, Jonathan E Kolitz, Ante S Lundberg, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2013
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpuraT C Wu, S Yang, S Haven, et al.
Nature|August 10, 1999
Creation of human tumour cells with defined genetic elementsW C Hahn, C M Counter, A S Lundberg, et al.
Headache|June 19, 2015
Reduced Baroreflex Sensitivity in Cluster Headache PatientsMads C J Barloese, Jesper Mehlsen, Louise Brinth, et al.
Gene|December 1, 1991
High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosusK S Lundberg, D D Shoemaker, M W Adams, et al.
Elife|July 22, 2021
Host-associated microbe PCR (hamPCR) enables convenient measurement of both microbial load and community compositionDerek S Lundberg, Pratchaya Pramoj Na Ayutthaya, Annett Strauß, et al.
Plos Pathogens|March 12, 2015
Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivationChandran Ramakrishna, Adrianna Ferraioli, Aleth Calle, et al.
Nature Communications|July 13, 2016
Host genotype and age shape the leaf and root microbiomes of a wild perennial plantMaggie R Wagner, Derek S Lundberg, Tijana G Del Rio, et al.
Critical Care Medicine|July 11, 1998
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care unitsJ S Lundberg, T M Perl, T Wiblin, et al.
Blood|August 24, 2011
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesMasha Fridkis-Hareli, Michael Storek, Istvan Mazsaroff, et al.
Pageof 18

Showing results (131-140 of 172) with videos related to

Sort By:
Pageof 18
Leukemia Research|September 15, 2009
Phase I trials of amonafide as monotherapy and in combination with cytarabine in patients with poor-risk acute myeloid leukemiaSteven L Allen, Jonathan E Kolitz, Ante S Lundberg, et al.
Journal of Thrombosis and Haemostasis : JTH|August 10, 2013
Complement activation and mortality during an acute episode of thrombotic thrombocytopenic purpuraT C Wu, S Yang, S Haven, et al.
Nature|August 10, 1999
Creation of human tumour cells with defined genetic elementsW C Hahn, C M Counter, A S Lundberg, et al.
Headache|June 19, 2015
Reduced Baroreflex Sensitivity in Cluster Headache PatientsMads C J Barloese, Jesper Mehlsen, Louise Brinth, et al.
Gene|December 1, 1991
High-fidelity amplification using a thermostable DNA polymerase isolated from Pyrococcus furiosusK S Lundberg, D D Shoemaker, M W Adams, et al.
Elife|July 22, 2021
Host-associated microbe PCR (hamPCR) enables convenient measurement of both microbial load and community compositionDerek S Lundberg, Pratchaya Pramoj Na Ayutthaya, Annett Strauß, et al.
Plos Pathogens|March 12, 2015
Establishment of HSV1 latency in immunodeficient mice facilitates efficient in vivo reactivationChandran Ramakrishna, Adrianna Ferraioli, Aleth Calle, et al.
Nature Communications|July 13, 2016
Host genotype and age shape the leaf and root microbiomes of a wild perennial plantMaggie R Wagner, Derek S Lundberg, Tijana G Del Rio, et al.
Critical Care Medicine|July 11, 1998
Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care unitsJ S Lundberg, T M Perl, T Wiblin, et al.
Blood|August 24, 2011
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseasesMasha Fridkis-Hareli, Michael Storek, Istvan Mazsaroff, et al.
Pageof 18